Comparison of misoprostol administration in second trimester pregnancy terminatio
Not Applicable
- Conditions
- Medical abortion.Medical abortion
- Registration Number
- IRCT138810193025N1
- Lead Sponsor
- Vice-chancellor for Research, Qazvin University of Medical Sciences and Health Services, Iran
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 140
Inclusion Criteria
pregnant women between 14 -28 weeks of gestation undergoing termination of pregnancy because of fetal anomalies, IUFD, PROM, severe Oligohydraminious, maternal diseases.
Exclusion criteria: uncontrolled heart diseases, acute asthmatic attack, glaucoma, history of cesarean section more than two times or classic cesarean section, previous incision on uterus, parity>6
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Interval between administeration of drug and expulsion of fetus. Timepoint: 24 hours, 48 hours after intervention. Method of measurement: Duration, in hours.
- Secondary Outcome Measures
Name Time Method Total dose of misoprostol administeration in termination of pregnancy. Timepoint: every 6 hours in teh first group, every 12 hours in the second group. Method of measurement: Total dose administered, in microgram.